Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
559 News Items found
Kenneth Offit, MD, MPH
Researchers Identify New Genetic Marker for Breast Cancer

An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this DNA variation are at a 1.4 times greater risk of developing breast cancer compared to those without the variation.
Pictured: James Allison
James Allison Elected to the Institute of Medicine

James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute, has been elected a member of the Institute of Medicine.
Lorenz Studer
Team Creates Muscle Cells from Embryonic Stem Cells

A team of Memorial Sloan Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.
Pictured: Johanna Joyce
Johanna Joyce Named to Geoffrey Beene Chair

Johanna Joyce, of the Sloan Kettering Institute's Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair.
Novel Regulation of the Common Tumor Suppressor PTEN

Researchers led by scientists at Memorial Sloan Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of <i>PTEN</i> function. The findings from two related studies are published in the January 12 issue of <i>Cell</i>.
Samuel Danishefsky
Chemist Samuel Danishefsky Wins Trio of Awards

Memorial Sloan Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan Kettering Institute.
Integrin Receptor Protein Found to Contribute To Tumor Angiogenesis

Scientists at Sloan Kettering Institute have discovered that the &#945;6&szlig;4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the &#945;6&szlig;4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.
Thomas Kelly
Thomas Kelly Wins General Motors Cancer Research Award

In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation.
Research Shows Therapeutic Cloning Can Cure Parkinson's-like Disease in Mice

NEW YORK, September 21, 2003 - New research from Memorial Sloan Kettering Cancer Center (MSKCC), Cornell University, and The University of Connecticut describes a novel way of producing therapeutic nerve cells that can cure mice with Parkinson's-like disease. The work, which will be published in the October issue of Nature Biotechnology (available online September 21), provides the first evidence that cloned cells can cure disease in an animal model.